|
Home:
Web Guide 2: Edward
Lin, MD: Selected references
Selected references
Abushullaih S et al. Incidence and severity of hand-foot
syndrome in colorectal cancer patients treated with capecitabine:
A single-institution experience. Cancer Invest 2002;20(1):3-10.
Abstract
Blanke CD. Celecoxib with chemotherapy in colorectal cancer.
Oncology 2002;16(4 Suppl 3):17-21. Abstract
Blanke CD et al. A phase II trial of celecoxib (CX), irinotecan
(I), 5-fluorouracil (5-FU), and leucovorin (LCV) in patients (pts)
with unresectable or metastatic colorectal cancer (CRC). Proc
ASCO 2002;Abstract
505.
Cianchi F et al. Up-regulation of cyclooxygenase-2 gene
expression correlates with tumor angiogenesis in human colorectal
cancer. Gastroenterology 2001;121(6):1339-47. Abstract
Dempke W et al. Cyclooxygenase-2: A novel target for cancer
chemotherapy? J Cancer Res Clin Oncol 2001;127(7):411-7.
Abstract
Grosch S et al. COX-2 independent induction of cell cycle
arrest and apoptosis in colon cancer cells by the selective COX-2
inhibitor celecoxib. FASEB J 2001;15(14):2742-4. Abstract
Gupta RA, Dubois RN. Colorectal cancer prevention and
treatment by inhibition of cyclooxygenase- 2. Nat Rev Cancer
2001;1(1):11-21. Abstract
Jansman FG et al. Management of chemotherapy-induced adverse
effects in the treatment of colorectal cancer. Drug Saf
2001;24(5):353-67. Abstract
Lin EH et al. Celecoxib attenuated capecitabine-induced
hand-and-foot syndrome (HFS) and diarrhea and improved time to tumor
progression in metastatic colorectal cancer (MCRC). Proc
ASCO 2002;Abstract
2364.
North GL. Celecoxib as adjunctive therapy for treatment
of colorectal cancer. Ann Pharmacother 2001;35(12):1638-43.
Abstract
Thun MJ et al. Nonsteroidal anti-inflammatory drugs as
anticancer agents: Mechanistic, pharmacologic and clinical issues.
J Natl Cancer Inst 2002;94(4):252-66. Abstract
Williams CS et al. A cyclooxygenase-2 inhibitor (SC-58125)
blocks growth of established human colon cancer xenografts.
Neoplasia 2001;3(5):428-36. Abstract
Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates
with advanced stages of colorectal cancer. Am J Gastroenterol
2002;97(4):1037-41. Abstract
|
